miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1
Display Omitted
Gespeichert in:
| Autor*in: |
Deng, Huixing [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a - Liao, Gary ELSEVIER, 2020, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:106 ; year:2018 ; pages:1072-1081 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.biopha.2018.07.024 |
|---|
| Katalog-ID: |
ELV043866093 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV043866093 | ||
| 003 | DE-627 | ||
| 005 | 20230624105343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181113s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.biopha.2018.07.024 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica |
| 035 | |a (DE-627)ELV043866093 | ||
| 035 | |a (ELSEVIER)S0753-3322(18)32096-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.86 |2 bkl | ||
| 100 | 1 | |a Deng, Huixing |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 |
| 264 | 1 | |c 2018 | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Non-small celllung cancer |2 Elsevier | |
| 650 | 7 | |a Chemoresistance |2 Elsevier | |
| 650 | 7 | |a miR-539 |2 Elsevier | |
| 650 | 7 | |a Cisplatin |2 Elsevier | |
| 650 | 7 | |a DCLK1 |2 Elsevier | |
| 700 | 1 | |a Qianqian, Geng |4 oth | |
| 700 | 1 | |a Ting, Ji |4 oth | |
| 700 | 1 | |a Aimin, Yang |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Liao, Gary ELSEVIER |t A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |d 2020 |g Amsterdam [u.a.] |w (DE-627)ELV004620771 |
| 773 | 1 | 8 | |g volume:106 |g year:2018 |g pages:1072-1081 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.biopha.2018.07.024 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 44.86 |j Hämatologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 106 |j 2018 |h 1072-1081 |g 10 | ||
| author_variant |
h d hd |
|---|---|
| matchkey_str |
denghuixingqianqiangengtingjiaiminyang:2018----:i59nacshmsniiiyoipaiinnmlcllnc |
| hierarchy_sort_str |
2018 |
| bklnumber |
44.86 |
| publishDate |
2018 |
| allfields |
10.1016/j.biopha.2018.07.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica (DE-627)ELV043866093 (ELSEVIER)S0753-3322(18)32096-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Deng, Huixing verfasserin aut miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 Elsevier Qianqian, Geng oth Ting, Ji oth Aimin, Yang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:106 year:2018 pages:1072-1081 extent:10 https://doi.org/10.1016/j.biopha.2018.07.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 106 2018 1072-1081 10 |
| spelling |
10.1016/j.biopha.2018.07.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica (DE-627)ELV043866093 (ELSEVIER)S0753-3322(18)32096-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Deng, Huixing verfasserin aut miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 Elsevier Qianqian, Geng oth Ting, Ji oth Aimin, Yang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:106 year:2018 pages:1072-1081 extent:10 https://doi.org/10.1016/j.biopha.2018.07.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 106 2018 1072-1081 10 |
| allfields_unstemmed |
10.1016/j.biopha.2018.07.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica (DE-627)ELV043866093 (ELSEVIER)S0753-3322(18)32096-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Deng, Huixing verfasserin aut miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 Elsevier Qianqian, Geng oth Ting, Ji oth Aimin, Yang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:106 year:2018 pages:1072-1081 extent:10 https://doi.org/10.1016/j.biopha.2018.07.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 106 2018 1072-1081 10 |
| allfieldsGer |
10.1016/j.biopha.2018.07.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica (DE-627)ELV043866093 (ELSEVIER)S0753-3322(18)32096-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Deng, Huixing verfasserin aut miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 Elsevier Qianqian, Geng oth Ting, Ji oth Aimin, Yang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:106 year:2018 pages:1072-1081 extent:10 https://doi.org/10.1016/j.biopha.2018.07.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 106 2018 1072-1081 10 |
| allfieldsSound |
10.1016/j.biopha.2018.07.024 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica (DE-627)ELV043866093 (ELSEVIER)S0753-3322(18)32096-1 DE-627 ger DE-627 rakwb eng 610 VZ 44.86 bkl Deng, Huixing verfasserin aut miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 Elsevier Qianqian, Geng oth Ting, Ji oth Aimin, Yang oth Enthalten in Elsevier Science Liao, Gary ELSEVIER A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a 2020 Amsterdam [u.a.] (DE-627)ELV004620771 volume:106 year:2018 pages:1072-1081 extent:10 https://doi.org/10.1016/j.biopha.2018.07.024 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.86 Hämatologie VZ AR 106 2018 1072-1081 10 |
| language |
English |
| source |
Enthalten in A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Amsterdam [u.a.] volume:106 year:2018 pages:1072-1081 extent:10 |
| sourceStr |
Enthalten in A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a Amsterdam [u.a.] volume:106 year:2018 pages:1072-1081 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Hämatologie |
| institution |
findex.gbv.de |
| topic_facet |
Non-small celllung cancer Chemoresistance miR-539 Cisplatin DCLK1 |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| authorswithroles_txt_mv |
Deng, Huixing @@aut@@ Qianqian, Geng @@oth@@ Ting, Ji @@oth@@ Aimin, Yang @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV004620771 |
| dewey-sort |
3610 |
| id |
ELV043866093 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043866093</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624105343.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biopha.2018.07.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043866093</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0753-3322(18)32096-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.86</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Deng, Huixing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-small celllung cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemoresistance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">miR-539</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cisplatin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DCLK1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qianqian, Geng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ting, Ji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aimin, Yang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Liao, Gary ELSEVIER</subfield><subfield code="t">A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004620771</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:106</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1072-1081</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biopha.2018.07.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.86</subfield><subfield code="j">Hämatologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">106</subfield><subfield code="j">2018</subfield><subfield code="h">1072-1081</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| author |
Deng, Huixing |
| spellingShingle |
Deng, Huixing ddc 610 bkl 44.86 Elsevier Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 |
| authorStr |
Deng, Huixing |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV004620771 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.86 bkl miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 Elsevier |
| topic |
ddc 610 bkl 44.86 Elsevier Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 |
| topic_unstemmed |
ddc 610 bkl 44.86 Elsevier Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 |
| topic_browse |
ddc 610 bkl 44.86 Elsevier Non-small celllung cancer Elsevier Chemoresistance Elsevier miR-539 Elsevier Cisplatin Elsevier DCLK1 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
g q gq j t jt y a ya |
| hierarchy_parent_title |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| hierarchy_parent_id |
ELV004620771 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV004620771 |
| title |
miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 |
| ctrlnum |
(DE-627)ELV043866093 (ELSEVIER)S0753-3322(18)32096-1 |
| title_full |
miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 |
| author_sort |
Deng, Huixing |
| journal |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| journalStr |
A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
1072 |
| author_browse |
Deng, Huixing |
| container_volume |
106 |
| physical |
10 |
| class |
610 VZ 44.86 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Deng, Huixing |
| doi_str_mv |
10.1016/j.biopha.2018.07.024 |
| dewey-full |
610 |
| title_sort |
mir-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting dclk1 |
| title_auth |
miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1 |
| url |
https://doi.org/10.1016/j.biopha.2018.07.024 |
| remote_bool |
true |
| author2 |
Qianqian, Geng Ting, Ji Aimin, Yang |
| author2Str |
Qianqian, Geng Ting, Ji Aimin, Yang |
| ppnlink |
ELV004620771 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.biopha.2018.07.024 |
| up_date |
2024-07-06T19:57:40.917Z |
| _version_ |
1803860952655855616 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV043866093</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624105343.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">181113s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.biopha.2018.07.024</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001692.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV043866093</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0753-3322(18)32096-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.86</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Deng, Huixing</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">miR-539 enhances chemosensitivity to cisplatin in non-small cell lung cancer by targeting DCLK1</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Non-small celllung cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemoresistance</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">miR-539</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cisplatin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">DCLK1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Qianqian, Geng</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ting, Ji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aimin, Yang</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Liao, Gary ELSEVIER</subfield><subfield code="t">A Scoping Review of Registered Clinical Trials of Cellular Therapy for COVID-19 and a</subfield><subfield code="d">2020</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV004620771</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:106</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:1072-1081</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.biopha.2018.07.024</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.86</subfield><subfield code="j">Hämatologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">106</subfield><subfield code="j">2018</subfield><subfield code="h">1072-1081</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| score |
7.402337 |